These cells are associated with disease flares in patients with SLE and are the likely source of pathogenic anti–double-stranded DNA (anti-dsDNA) IgG2a and IgG3 autoantibodies 23. The gene discussed is IGHG3; the disease is systemic lupus erythematosus.